6505--Nadolol Tablets

The Department of Veterans Affairs National Acquisition Center is seeking a requirements contract for Nadolol tablets across three strengths: 20mg, 40mg, and 80mg. The solicitation (36E79725R0014) aims to establish a contract for distributing these tablets through VA and DoD Pharmaceutical Prime Vendor (PPV) Programs, with each bottle containing 100 tablets. Contractors must provide unique 11-digit NDC numbers, maintain FDA compliance, and establish business agreements with PPV contractors within a 60-day implementation period. Proposals must be submitted via email to Richard.Mahario@va.gov and Nicholas.McGregor@va.gov by January 22, 2025, at 2:30 PM CT. The evaluation will consider pricing, which must include a 0.5% Cost Recovery Fee, and proposals from manufacturers or those with a Letter of Commitment from a manufacturer will be accepted. Additionally, while the solicitation is unrestricted, it includes a HUBZone price evaluation preference.

The contract will serve multiple federal facilities, including VA facilities, DoD PPV Program participants, Indian Health Service facilities, Bureau of Prisons facilities, Federal Health Care Center, and Option 2 State Veteran Homes. The annual quantities are significant: 7,753 bottles of 20mg, 6,085 bottles of 40mg, and 1,566 bottles of 80mg. The contract structure includes a base year with four one-year option periods, providing potential long-term stability for the selected contractor. While specific award values are not detailed, the broad range of facilities and substantial annual quantities suggest a meaningful procurement opportunity. The solicitation does not indicate a specific set-aside, making it open to various types of businesses, though the HUBZone preference provides an advantage to qualified small businesses. Contractors will need to demonstrate capability to meet the comprehensive distribution requirements across multiple federal healthcare systems.